Physician profile
Tanner Smith
NPI 1336570613
$1,648.54
in general payments reported to CMS, 2019-2025
12 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $302 · 2023: $311 · 2024: $239 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $650.92 | 2022-2025 | Corevalve Evolut R, Penditure, Avalus |
| Pfizer INC. | $248.51 | 2023-2025 | |
| Ethicon US, LLC | $198.16 | 2021 | |
| Atricure, INC. | $116.66 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Abbott Laboratories | $98.78 | 2025 | Navitor |
| Zimmer Biomet Holdings, INC. | $76.09 | 2024 | Sternalock Blu System |
| Stryker Corporation | $63.93 | 2021 | |
| Tenex Health INC. | $52.21 | 2021 | |
| Edwards Lifesciences Corporation | $49.46 | 2025 | Carpentier-Edwards Physio II Annuloplasty Ring |
| Astrazeneca Pharmaceuticals Lp | $42.33 | 2023 | Tagrisso |
| Corcym INC | $37.74 | 2025 | Perceval |
| Merck Sharp & Dohme LLC | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.